KNOREX Ltd.

Our Company was incorporated in the Cayman Islands on May 9, 2023, under the Companies Act as an exempted company with limited liability. As of December 31, 2023, our authorized share capital was US$50,000 divided into 5,000,000 ordinary shares of par value US$0.01 each. On February 26, 2024, the authorized share capital of our Company was amended to US$50,000 divided into 100,000,000 ordinary shares of par value US$0.0005 each of a single class. On September 25, 2024, the authorized share capital of our Company was further amended to US$50,000 divided into 100,000,000 ordinary shares of par value US$0.0005 each, comprising 90,000,000 Class A Ordinary Shares of par value US$0.0005 each and 10,000,000 Class B Ordinary Shares of par value US$0.0005 each. Pursuant to a restructuring agreement dated September 30, 2024 (the Restructuring Agreement ), the shareholders of KNOREX SG transferred all of their preference and ordinary shares in KNOREX SG to the Company thus completing the Reorganization then resulting in KNOREX SG being 100% fully owned by the Company. In consideration thereof, the Company had allotted and issued an aggregate of 22,477,825 Class A Ordinary Shares and 4,780,575 Class B Ordinary Shares of the Company to the shareholders of KNOREX SG and certain other persons, in accordance with and subject to the terms of the Restructuring Agreement.